Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.12
GNC's Cash to Debt is ranked lower than
84% of the 350 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.60 vs. GNC: 0.12 )
Ranked among companies with meaningful Cash to Debt only.
GNC' s 10-Year Cash to Debt Range
Min: 0.06  Med: 0.15 Max: N/A
Current: 0.12
Equity to Asset 0.27
GNC's Equity to Asset is ranked lower than
80% of the 333 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.45 vs. GNC: 0.27 )
Ranked among companies with meaningful Equity to Asset only.
GNC' s 10-Year Equity to Asset Range
Min: 0.23  Med: 0.33 Max: 0.42
Current: 0.27
0.23
0.42
Interest Coverage 9.72
GNC's Interest Coverage is ranked lower than
70% of the 242 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.05 vs. GNC: 9.72 )
Ranked among companies with meaningful Interest Coverage only.
GNC' s 10-Year Interest Coverage Range
Min: 2.02  Med: 3.77 Max: 10.74
Current: 9.72
2.02
10.74
F-Score: 6
Z-Score: 3.38
M-Score: -2.66
WACC vs ROIC
10.10%
14.41%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 16.40
GNC's Operating margin (%) is ranked higher than
96% of the 351 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.81 vs. GNC: 16.40 )
Ranked among companies with meaningful Operating margin (%) only.
GNC' s 10-Year Operating margin (%) Range
Min: 10.24  Med: 13.63 Max: 17.61
Current: 16.4
10.24
17.61
Net-margin (%) 9.55
GNC's Net-margin (%) is ranked higher than
93% of the 351 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.74 vs. GNC: 9.55 )
Ranked among companies with meaningful Net-margin (%) only.
GNC' s 10-Year Net-margin (%) Range
Min: 3.3  Med: 6.39 Max: 10.09
Current: 9.55
3.3
10.09
ROE (%) 33.38
GNC's ROE (%) is ranked higher than
95% of the 342 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.26 vs. GNC: 33.38 )
Ranked among companies with meaningful ROE (%) only.
GNC' s 10-Year ROE (%) Range
Min: 11.7  Med: 21.28 Max: 32.56
Current: 33.38
11.7
32.56
ROA (%) 9.25
GNC's ROA (%) is ranked higher than
85% of the 352 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.50 vs. GNC: 9.25 )
Ranked among companies with meaningful ROA (%) only.
GNC' s 10-Year ROA (%) Range
Min: 3.01  Med: 7.45 Max: 10.02
Current: 9.25
3.01
10.02
ROC (Joel Greenblatt) (%) 59.55
GNC's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 352 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.36 vs. GNC: 59.55 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
GNC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 41.63  Med: 64.37 Max: 72.54
Current: 59.55
41.63
72.54
Revenue Growth (3Y)(%) 12.60
GNC's Revenue Growth (3Y)(%) is ranked higher than
83% of the 291 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. GNC: 12.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
GNC' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0  Med: 7.80 Max: 12.6
Current: 12.6
0
12.6
EBITDA Growth (3Y)(%) 19.30
GNC's EBITDA Growth (3Y)(%) is ranked higher than
84% of the 262 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.70 vs. GNC: 19.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
GNC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: 19.70 Max: 20.9
Current: 19.3
0
20.9
EPS Growth (3Y)(%) 31.30
GNC's EPS Growth (3Y)(%) is ranked higher than
86% of the 222 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.20 vs. GNC: 31.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
GNC' s 10-Year EPS Growth (3Y)(%) Range
Min: 0  Med: 39.35 Max: 58.1
Current: 31.3
0
58.1
» GNC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

GNC Guru Trades in Q2 2014

Louis Moore Bacon 30,000 sh (New)
Richard Snow 15,400 sh (New)
Jim Simons 343,000 sh (+247.52%)
Joel Greenblatt 861,384 sh (+136.62%)
Mario Gabelli 16,205 sh (+20.30%)
RS Investment Management 1,275,693 sh (+2.58%)
John Keeley Sold Out
Columbia Wanger 1,640,600 sh (-36.12%)
Paul Tudor Jones 10,394 sh (-73.88%)
» More
Q3 2014

GNC Guru Trades in Q3 2014

Private Capital 420,786 sh (New)
Paul Tudor Jones 21,913 sh (+110.82%)
Richard Snow 21,900 sh (+42.21%)
Louis Moore Bacon Sold Out
Jim Simons Sold Out
RS Investment Management 1,205,573 sh (-5.50%)
Mario Gabelli 14,420 sh (-11.02%)
Joel Greenblatt 550,896 sh (-36.05%)
Columbia Wanger 969,600 sh (-40.90%)
» More
Q4 2014

GNC Guru Trades in Q4 2014

Steven Cohen 515,000 sh (New)
Richard Snow 21,900 sh (unchged)
Private Capital 413,451 sh (-1.74%)
RS Investment Management 1,032,933 sh (-14.32%)
Mario Gabelli 11,820 sh (-18.03%)
Paul Tudor Jones 17,147 sh (-21.75%)
Columbia Wanger 608,500 sh (-37.24%)
Joel Greenblatt 291,457 sh (-47.09%)
» More
Q1 2015

GNC Guru Trades in Q1 2015

Jim Simons 543,900 sh (New)
Joel Greenblatt 458,147 sh (+57.19%)
Columbia Wanger Sold Out
Paul Tudor Jones Sold Out
Private Capital 410,089 sh (-0.81%)
RS Investment Management 609,213 sh (-41.02%)
Mario Gabelli 6,820 sh (-42.30%)
Richard Snow 11,900 sh (-45.66%)
Steven Cohen 88,600 sh (-82.80%)
» More
» Details

Insider Trades

Latest Guru Trades with GNC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about GNC Holdings Inc

Private Capital Reduces Holdings in Healthcare Stocks
Gregg Powers, who became CEO of Private Capital (Trades, Portfolio) Management when founder Bruce Sherman retired five years ago, began his career as a healthcare analyst at Raymond James Financial. Consequently, it should come as no surprise that healthcare stocks represent a little more than one-fifth of the content of the firm’s portfolio. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 16.10
GNC's P/E(ttm) is ranked higher than
74% of the 280 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 23.20 vs. GNC: 16.10 )
Ranked among companies with meaningful P/E(ttm) only.
GNC' s 10-Year P/E(ttm) Range
Min: 11.75  Med: 18.32 Max: 31.9
Current: 16.1
11.75
31.9
Forward P/E 13.18
GNC's Forward P/E is ranked higher than
60% of the 162 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.13 vs. GNC: 13.18 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 16.10
GNC's PE(NRI) is ranked higher than
75% of the 280 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 23.70 vs. GNC: 16.10 )
Ranked among companies with meaningful PE(NRI) only.
GNC' s 10-Year PE(NRI) Range
Min: 11.75  Med: 18.36 Max: 31.9
Current: 16.1
11.75
31.9
P/B 5.51
GNC's P/B is ranked lower than
89% of the 340 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.92 vs. GNC: 5.51 )
Ranked among companies with meaningful P/B only.
GNC' s 10-Year P/B Range
Min: 2.17  Med: 4.59 Max: 6.81
Current: 5.51
2.17
6.81
P/S 1.54
GNC's P/S is ranked lower than
83% of the 349 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.51 vs. GNC: 1.54 )
Ranked among companies with meaningful P/S only.
GNC' s 10-Year P/S Range
Min: 0.92  Med: 1.61 Max: 2.3
Current: 1.54
0.92
2.3
PFCF 17.08
GNC's PFCF is ranked higher than
53% of the 190 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 19.37 vs. GNC: 17.08 )
Ranked among companies with meaningful PFCF only.
GNC' s 10-Year PFCF Range
Min: 12.82  Med: 20.97 Max: 34.5
Current: 17.08
12.82
34.5
POCF 13.36
GNC's POCF is ranked lower than
53% of the 262 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 12.83 vs. GNC: 13.36 )
Ranked among companies with meaningful POCF only.
GNC' s 10-Year POCF Range
Min: 10.21  Med: 16.37 Max: 25.23
Current: 13.36
10.21
25.23
EV-to-EBIT 11.85
GNC's EV-to-EBIT is ranked higher than
71% of the 296 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.71 vs. GNC: 11.85 )
Ranked among companies with meaningful EV-to-EBIT only.
GNC' s 10-Year EV-to-EBIT Range
Min: 9.2  Med: 12.40 Max: 15.2
Current: 11.85
9.2
15.2
PEG 0.90
GNC's PEG is ranked higher than
86% of the 140 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.16 vs. GNC: 0.90 )
Ranked among companies with meaningful PEG only.
GNC' s 10-Year PEG Range
Min: 0.46  Med: 0.67 Max: 0.73
Current: 0.9
0.46
0.73
Current Ratio 3.26
GNC's Current Ratio is ranked higher than
91% of the 335 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.21 vs. GNC: 3.26 )
Ranked among companies with meaningful Current Ratio only.
GNC' s 10-Year Current Ratio Range
Min: 2.88  Med: 3.11 Max: 3.91
Current: 3.26
2.88
3.91
Quick Ratio 1.26
GNC's Quick Ratio is ranked higher than
79% of the 335 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.74 vs. GNC: 1.26 )
Ranked among companies with meaningful Quick Ratio only.
GNC' s 10-Year Quick Ratio Range
Min: 0.93  Med: 1.23 Max: 1.85
Current: 1.26
0.93
1.85
Days Inventory 128.10
GNC's Days Inventory is ranked lower than
94% of the 343 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 37.69 vs. GNC: 128.10 )
Ranked among companies with meaningful Days Inventory only.
GNC' s 10-Year Days Inventory Range
Min: 111.33  Med: 116.16 Max: 124.85
Current: 128.1
111.33
124.85
Days Sales Outstanding 18.91
GNC's Days Sales Outstanding is ranked lower than
61% of the 286 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.38 vs. GNC: 18.91 )
Ranked among companies with meaningful Days Sales Outstanding only.
GNC' s 10-Year Days Sales Outstanding Range
Min: 19.05  Med: 19.62 Max: 20.17
Current: 18.91
19.05
20.17

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.52
GNC's Dividend Yield is ranked lower than
61% of the 444 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.89 vs. GNC: 1.52 )
Ranked among companies with meaningful Dividend Yield only.
GNC' s 10-Year Dividend Yield Range
Min: 0.27  Med: 1.18 Max: 1.9
Current: 1.52
0.27
1.9
Dividend Payout 0.24
GNC's Dividend Payout is ranked higher than
68% of the 273 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.37 vs. GNC: 0.24 )
Ranked among companies with meaningful Dividend Payout only.
GNC' s 10-Year Dividend Payout Range
Min: 0.18  Med: 0.21 Max: 0.3
Current: 0.24
0.18
0.3
Yield on cost (5-Year) 1.52
GNC's Yield on cost (5-Year) is ranked lower than
64% of the 446 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.05 vs. GNC: 1.52 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
GNC' s 10-Year Yield on cost (5-Year) Range
Min: 0.27  Med: 1.18 Max: 1.9
Current: 1.52
0.27
1.9
Share Buyback Rate 4.10
GNC's Share Buyback Rate is ranked higher than
88% of the 195 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.40 vs. GNC: 4.10 )
Ranked among companies with meaningful Share Buyback Rate only.
GNC' s 10-Year Share Buyback Rate Range
Min: 0  Med: 0.50 Max: -6.1
Current: 4.1

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.96
GNC's Price/Median PS Value is ranked higher than
71% of the 329 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.16 vs. GNC: 0.96 )
Ranked among companies with meaningful Price/Median PS Value only.
GNC' s 10-Year Price/Median PS Value Range
Min: 0.61  Med: 1.02 Max: 1.35
Current: 0.96
0.61
1.35
Price/Peter Lynch Fair Value 0.68
GNC's Price/Peter Lynch Fair Value is ranked higher than
90% of the 81 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.65 vs. GNC: 0.68 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
GNC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.67  Med: 0.71 Max: 0.74
Current: 0.68
0.67
0.74
Earnings Yield (Greenblatt) (%) 8.40
GNC's Earnings Yield (Greenblatt) (%) is ranked higher than
75% of the 345 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.50 vs. GNC: 8.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
GNC' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 6.6  Med: 8.10 Max: 10.8
Current: 8.4
6.6
10.8
Forward Rate of Return (Yacktman) (%) 27.88
GNC's Forward Rate of Return (Yacktman) (%) is ranked higher than
88% of the 218 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.74 vs. GNC: 27.88 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
GNC' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 27.6  Med: 27.90 Max: 36.9
Current: 27.88
27.6
36.9

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare: » details
Traded in other countries:IGN.Germany,
GNC Holdings Inc was founded in 1935. It is a specialty retailer of health and wellness products, including VMHS products, sports nutrition products, and diet products. The Company's business segments include: Retail, Franchising and Manufacturing/Wholesale. Its retail segment is engaged in sales of products to customers at its company-owned stores in the United States, Canada and Puerto Rico and through its websites, GNC.com, LuckyVitamin.com and DiscountSupplements.com. As of December 31, 2013, the Company operated 3,342 company-owned stores across all 50 states including the District of Columbia, Canada and Puerto Rico. Its franchise segment consists of its domestic and international franchise operations, and engaged in franchise activities mainly product sales to franchisees, royalties on franchise retail sales and franchise fees. As of December 31, 2013, there were 3,036 franchise stores operating, including 1,012 stores in the U.S. and 2,024 international franchise stores operating in over 50 international countries. Its franchise stores in the United States offer both its proprietary products and third-party products, with a product selection similar to that of its company-owned stores. Its international franchise stores are offered a more limited product selection than its franchise stores in the United States with the product selection heavily weighted toward proprietary products. Manufacturing/Wholesale segment consists of manufacturing operations in South Carolina and its wholesale sales business. This segment supplies its Retail and Franchise segments as well as various third parties with finished products. Its Manufacturing/Wholesale segment is engaged in sales of manufactured products to third parties, and the sale of its proprietary and third-party brand products to Rite Aid, Sam's Club, PetSmart and www.drugstore.com. Its wholesale operations are supported mainly by its Anderson, South Carolina distribution center. The Company's sales are in four major nutritional supplement categories: VMHS, sports nutrition, diet and other wellness. It offers high-quality nutritional supplements sold under its GNC proprietary brand names, including Mega Men, Ultra Mega, Total LeanTM, Pro Performance and Pro Performance AMP, Beyond Raw and under nationally recognized third-party brand names. Its online channels are, GNC.com, LuckyVitamin.com and DiscountSupplements.com. It competes with other specialty retailers, supermarkets, drugstores, mass merchants, multi-level marketing organizations, mail-order companies, other internet sites and a variety of other smaller participants. The Company is subject to also subject to regulation under various national, local and international laws.
» More Articles for GNC

Headlines

Articles On GuruFocus.com
Private Capital Reduces Holdings in Healthcare Stocks Dec 18 2014 
Why GNC Holdings Is a Good Buy Despite a Mixed Quarter Nov 30 2014 
Why Investors Should Expect a Turnaround at GNC Holdings Nov 18 2014 
These Health Retailers Are Enticing Long-Term Bets Aug 06 2014 
GNC Could Generate a 55% Return May 08 2014 
Herbalife and GNC Are Good Investments, Here’s Why Apr 17 2014 
Top 5 Stocks from TPG-Axon Mar 21 2013 
Billionaire Steven Cohen Vitamins Up with GNC Mar 04 2013 
Generac Holdings: Umbrellas Sell Better on and After Rainy Days Nov 28 2012 
President and CEO of GNC Holdings Inc. Joe Fortunato Sold 50,000 Shares Aug 08 2012 

More From Other Websites
Edited Transcript of GNC earnings conference call or presentation 30-Apr-15 1:00pm GMT Jun 30 2015
Nutritional Supplement Industry Flexes its Muscles as Natural & Pharmaceutical Supplement Products... Jun 29 2015
Vitamins Boost China By Way Of By-Health Jun 24 2015
Transactions in relation to share buyback program Jun 19 2015
Watch Your Hearing at this year’s Folkemøde 2015 on Bornholm Jun 17 2015
GNC Holdings Inc. (GNC) in Focus: Stock Jumps 5.6% - Tale of the Tape Jun 11 2015
Transactions in relation to share buyback program Jun 11 2015
Coverage initiated on GNC Holdings by Macquarie Jun 09 2015
FitLife Brands, Inc.: Gathering momentum, can it sustain its performance? Jun 03 2015
Transactions in relation to share buyback program May 27 2015
GNC Holdings, Inc. to present at the 2015 Stephens Spring Investment Conference May 26 2015
GNC Holdings, Inc. to present at the 2015 Stephens Spring Investment Conference May 26 2015
Bulls are betting on GNC rebound May 26 2015
GNC HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 21 2015
Chairman of the board acquires GN shares May 13 2015
Member of the board acquires GN shares May 12 2015
Gatorade Turns 50: What the Sports Drink Must Do to Keep Its Edge May 12 2015
Vitamin Shoppe Cuts Guidance, Earnings Fall May 06 2015
Transactions in relation to share buyback program May 05 2015
Total number of voting rights and share capital in GN Store Nord A/S May 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK